Author: John Carreyrou
Narrator: Ryan
Format: MP3
IBSN:
Language: English
Publish Date: 21/05/2018
Audiobook length: 31 min
Chapter 2Why was Elizabeth Holmes’ blood-testing technology unfeasible Chapter 3How did Theranos manage to achieve an estimated value of $9 billion USD Chapter 4How was Holmes’ deception unraveled Chapter 5Summary & Review Listening to the summary audiobook of "Bad Blood" by John Carreyrou offers a compelling insight into the thrilling and cautionary tale of the rise and fall of Theranos and its founder, Elizabeth Holmes. Condensing the key themes of ambition, deceit, and the consequences of prioritizing vision over ethics, the summary provides a quick yet impactful understanding of the intricate narrative and high-stakes drama that captivated the business world and beyond. It serves as a vital lesson in the importance of due diligence and accountability in innovation, making it essential for entrepreneurs, investors, and anyone interested in the intersections of technology and ethics.
John Carreyrou, an experienced investigative journalist from The Wall Street Journal. On two separate occasions, he has been awarded the Pulitzer Prize. Additionally, he received the George Polk Award for Financial Reporting and the Bartlett & Steele Silver Award for Investigative Business Journalism. Bad Blood, his debut book, has won him numerous prestigious accolades, including the Financial Times and McKinsey Business Book of the Year Award.
- The rise and fall of Theranos, fueled by Elizabeth Holmes’ charisma and vision, showcases how ambition can lead to ethical compromises in the tech industry. The company promised revolutionary blood-testing technology but ultimately relied on deception to maintain its facade.
- John Carreyrou's investigative journalism reveals the dangerous consequences of unchecked innovation, especially when investors prioritize hype over due diligence. The story serves as a cautionary tale about the importance of transparency and accountability in startups.
- The involvement of high-profile board members and endorsements highlights how reputation can be exploited to legitimize fraud. 'Bad Blood' emphasizes the need for rigorous oversight in the healthcare sector to protect public trust and safety.
Brief In, Brilliance Out
Contact: buildlearn.bk@gmail.com
Author: John Carreyrou
Narrator: Ryan
Format: MP3
IBSN:
Language: English
Publish Date: 21/05/2018
Audiobook length: 31 min
Chapter 2Why was Elizabeth Holmes’ blood-testing technology unfeasible Chapter 3How did Theranos manage to achieve an estimated value of $9 billion USD Chapter 4How was Holmes’ deception unraveled Chapter 5Summary & Review 10 Judgements That Changed India
Listening to the summary audiobook of "Bad Blood" by John Carreyrou offers a compelling insight into the thrilling and cautionary tale of the rise and fall of Theranos and its founder, Elizabeth Holmes. Condensing the key themes of ambition, deceit, and the consequences of prioritizing vision over ethics, the summary provides a quick yet impactful understanding of the intricate narrative and high-stakes drama that captivated the business world and beyond. It serves as a vital lesson in the importance of due diligence and accountability in innovation, making it essential for entrepreneurs, investors, and anyone interested in the intersections of technology and ethics.
John Carreyrou, an experienced investigative journalist from The Wall Street Journal. On two separate occasions, he has been awarded the Pulitzer Prize. Additionally, he received the George Polk Award for Financial Reporting and the Bartlett & Steele Silver Award for Investigative Business Journalism. Bad Blood, his debut book, has won him numerous prestigious accolades, including the Financial Times and McKinsey Business Book of the Year Award.
- The rise and fall of Theranos, fueled by Elizabeth Holmes’ charisma and vision, showcases how ambition can lead to ethical compromises in the tech industry. The company promised revolutionary blood-testing technology but ultimately relied on deception to maintain its facade.
- John Carreyrou's investigative journalism reveals the dangerous consequences of unchecked innovation, especially when investors prioritize hype over due diligence. The story serves as a cautionary tale about the importance of transparency and accountability in startups.
- The involvement of high-profile board members and endorsements highlights how reputation can be exploited to legitimize fraud. 'Bad Blood' emphasizes the need for rigorous oversight in the healthcare sector to protect public trust and safety.
Brief In, Brilliance Out
Contact: buildlearn.bk@gmail.com
